1. PhXA34, a new potent ocular hypotensive drug;Alm;A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch Ophthalmol,1991
2. Intraocular pressurereducing effect of PhXA41 in patients with increased eye pressure;Alm;A one-month study. Ophthalmology,1993
3. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol;Alm;BrJ Ophthalmol,1995
4. Effects on intraocular pressure and side effects of 0.005% latanoprost once daily, evening or morning;Alto;A comparison with timolol. Ophthalmology,1995
5. Intraocular pressure reduction with PhXA34, a new prostaglandin analogue, in patients with ocular hypertension;Camras;Arch Ophthalmol,1992